Skip to main content
S&P 5007,772.56-0.59%DOW50,999.10-1.01%NASDAQ27,395.44-0.74%BTC$83,082.00-3.52%ETH$2,562.06-5.45%GOLD$4,125.20-1.48%OIL$89.87+0.48%
Smart Investors Daily
SID Premium
NM

NASDAQ · NMTC

NeuroOne Medical Technologies Corporation

Healthcare · Medical - Devices

$1.13

Down-$0.03 (-2.65%)

Updated Oct 7, 2026, 2:38 PM

SID Score

4.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
29.33M
P/E ratio
-5.35
Dividend yield
0.00%
52-week range
$0.70 – $5.40
Volume
118.97K
Avg. volume
334.87K

Price performance · NMTC

NMTC price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 6, 2026

NMTC closed at $1.13 after 21 trading sessions, down 33.14% for the selected period.

Last close
$1.13
Period change
-33.14%
Period low
$0.99
Period high
$1.69
Daily close
View OHLC price history
NMTC OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 6, 2026$1.13$1.17$1.10$1.13118.97K
Oct 5, 2026$1.18$1.35$1.10$1.1151M
Oct 2, 2026$0.98$1.20$0.9746$1.12201.38K
Oct 1, 2026$1.03$1.0732$0.9615$0.9851125.38K
Sep 30, 2026$1.13$1.14$1.01$1.0367.96K
Sep 29, 2026$1.29$1.32$1.05$1.09315.46K
Sep 28, 2026$1.31$1.34$1.29$1.3030.19K
Sep 25, 2026$1.33$1.3484$1.28$1.33120.79K
Sep 24, 2026$1.36$1.39$1.33$1.33191.1K
Sep 23, 2026$1.40$1.42$1.34$1.34168.25K
Sep 22, 2026$1.34$1.40$1.31$1.38100.93K
Sep 21, 2026$1.41$1.41$1.30$1.3077.73K
Sep 18, 2026$1.39$1.40$1.35$1.39149.46K
Sep 17, 2026$1.48$1.52$1.35$1.36370.43K
Sep 16, 2026$1.43$1.48$1.375$1.4184.62K
Sep 15, 2026$1.51$1.52$1.43$1.4672.91K
Sep 14, 2026$1.57$1.58$1.50$1.5038.79K
Sep 11, 2026$1.59$1.60$1.55$1.5664.23K
Sep 10, 2026$1.65$1.67$1.56$1.58225.22K
Sep 9, 2026$1.71$1.725$1.63$1.6699.7K
Sep 8, 2026$1.68$1.73$1.58$1.69275.01K

Latest NMTC news

The latest Smart Investors Daily articles mentioning NMTC.

Stock researchCompany · Overview

NMTC research

Overview

Company profile and research snapshot.

Company profile

NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$3.00
Implied upside
—
Analysts
—
NMTC recent ratings
DateFirmRatingTarget
Aug 14, 2026Maxim GroupBuy—
May 13, 2026Ladenburg ThalmannBuy—
Mar 2, 2026Jones TradingBuy—
Sep 9, 2025Maxim GroupBuy—
May 5, 2025Ladenburg ThalmannBuy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 17, 2026

NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement

Agreement Covers Key Southern California Counties Including Los Angeles Metro as NeuroOne Broadens Commercial Access in Key U.S. MarketsEDEN PRAIRIE, Minn., Sept. 17, 2026 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on transforming the surgical diagnosis and treatment of neurological disorders, today announced a new Southern California distribution agreement for its FDA-cleared OneRF® Trigeminal

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By